Transthyretin Amyloid Cardiomyopathy (ATTR-CM) - American Heart Association Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed and potentially fatal disease of the heart muscle As it progresses, the heart can become unable to adequately squeeze to pump blood out of the heart, ultimately leading to heart failure
Transthyretin Amyloidosis (ATTR) for Professionals Video webinar series helps instructs healthcare professionals in improving care and treatment for patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Advancing access to clinical trials for cardiomyopathy As part of this work, the Association today announced an initiative to improve education, outreach and access to clinical trials for gene editing therapies for transthyretin amyloid cardiomyopathy (ATTR-CM) ATTR-CM is a progressive and often underdiagnosed condition that disproportionately affects older adults and certain racial and ethnic groups
Guidelines in a New Era for Cardiac Amyloidosis After making a diagnosis of ATTR-CM, this Scientific Statement delves into the critical importance of next distinguishing familial disease (ATTRv) from non-familial disease (ATTRwt) Rationale for this recommendation arises from the need to counsel and assess risk in first-degree relatives, to assess prognosis, and to choose appropriate treatments
Webinars - Professional Heart Daily | American Heart Association Improving Care of Patients with ATTR-CM In this 3-part series, watch AHA volunteer experts discussing ways to empower patients to recognize ATTR-CM and share in decision-making about diagnostic and treatment options CE ABIM MOC credit available Approved for up to 3 0 AAFP Prescribed Elective credits Free webinar
Hereditary Transthyretin-Mediated Amyloidosis (hATTR) Clinical Clues . . . The list of clinical clues and diagnostic testing provided in this quick reference guide are intended to promote earlier identification and accurate diagnosis of ATTR amyloidosis, with subsequent genetic testing to determine if there is a genetic cause
What Is Cardiomyopathy? - American Heart Association Restrictive cardiomyopathy Arrhythmogenic right ventricular dysplasia Transthyretin amyloid cardiomyopathy (ATTR-CM) Some other types of cardiomyopathy are called “unclassified cardiomyopathy ” Another type, which usually follows acute emotional stress, is “stress-induced cardiomyopathy,” also known as broken heart syndrome
Your Guide to Gene Editing and Clinical Trials for Heart Health To join a gene editing trial, a person usually needs to meet certain requirements, such as: 1 Having a confirmed diagnosis of a genetic condition that affects the heart, like ATTR-CM 2 Having specific health conditions and or a genetic marker (a tiny part of your genes that can show where something important is located) that match the trial’s